Webinar Overview

Venous thromboembolism (VTE) is a potentially preventable disease that includes Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). VTE events often result in complications such as post thrombotic syndrome, pulmonary hypertension, recurrent thrombosis, and even death. In Australia VTE is estimated to account for 10% of all hospital deaths and costs the health care system $1.72 billion annually¹. Furthermore, despite the availability of international evidence-based guidelines for the prevention of VTE, data suggests that a significant proportion of patients at risk of VTE do not receive adequate preventative measures^2-4.

In collaboration with the Australian College of Nursing, Arjo are delighted to welcome Rodney Neale to present this year’s World Thrombosis Day webinar. Rodney’s presentation will provide an overview of VTE, its complications and most importantly how we as clinicians, in collaboration with patients and carers, can potentially prevent VTE events occurring. Rodney will explore the Australian VTE Prevention Clinical Care Standard which provides guidance to consumers, clinicians and health services on the care recommended to prevent VTE acquired in hospital and following hospital discharge.

Date: Thursday 10^th October

Time: 2-3pm EST

Topic: An Introduction VTE Prevention and the Australian Clinical Care Standard

Location: Online

Who should attend: Nurses and Clinicians interested in VTE outcomes

Speaker: Rodney Neale, Venous Thromboembolism Clinical Nurse Consultant, Princess Alexandra Hospital

Rodney is a member of the working group which developed the Venous Thromboembolism Prevention Clinical Care Standard for the Australian Commission on Safety and Quality in Health Care and is currently on the Queensland state-wide VTE working party which has recently published the first Queensland state-wide VTE prophylaxis guideline.

References

1. Access Economics Pty Ltd for the Australia and New Zealand working party on the management and prevention of venous thromboembolism. The burden of venous thromboembolism in Australia, 1 May 2008. Access Economics Pty Ltd; 2008.
2. Cohen AT, Tapson VF, Bergmann J-F,Goldhaber SZ, Kakkar AK, Deslandes B, et al.Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–94.
3. Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119(2):145–55.
4. Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936–45.